Sesame is fast becoming a risky ingredient as allergy rates soar – driving the FDA to explore warning labels for foods that contain the nutty white seeds.
For decades, the agency’s list of common food allergens has consisted of eight products which cause 90% of reactions: milk, eggs, peanuts, wheat, fish, shellfish, tree nuts, and soybeans.
That list is set to grow to incorporate sesame, since new data suggest that now more than 0.1 % of Americans have sesame allergies, the same prevalence as fish and soy allergies.
Allergy Therapeutics (LON:AGY) is an international speciality pharmaceutical group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines, that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.
